CASEY HARGETT: Open Payments
NPI 1487187068 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 22 payments from 8 companies in 2025. Trend: 2023 $1,954 · 2024 $1,365 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $233 |
| Exeltis, USA Inc. | 3 | $49 |
| ABBVIE INC. | 2 | $41 |
| Gilead Sciences, Inc. | 1 | $28 |
| MILLICENT US INC | 1 | $16 |
| Amgen Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $10 |
Products named: Veozah, SLYND, QULIPTA, LILETTA, INTRAROSA, EVENITY, Mirena.
Industry payments across MS — which companies pay providers there.
